REON Financials 07/16/2014 14:23:35
Resolute Oncology Inc.
Period Ending Dec 31, 2012 Dec 31, 2011
Total Revenue - -
Cost of Revenue - -
Gross Profit - -
Operating Expenses
Research and Development - -
Sales, General and Admin. 21 6
Non-Recurring Items 40 8
Other - -
Operating Income (60) (13)
Income From Continuing Operations
Add'l Income/Expense Items - -
Earnings Before Interest and Tax (60) (13)
Interest Expense 1 -
Earnings Before Tax (61) (13)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (61) (13)
Non Recurring Events
Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (61) (13)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (61) (13)